Stefanie Schmidt
Siemens Healthcare (United States)(US)
Publications by Year
Research Areas
Mechanical Circulatory Support Devices, HER2/EGFR in Cancer Research, Cell Adhesion Molecules Research, Lung Cancer Treatments and Mutations, Global Cancer Incidence and Screening
Most-Cited Works
- → ADAM17 is required for EGF-R–induced intestinal tumors via IL-6 trans-signaling(2018)76 cited
- → Mechanistic insights into a TIMP3-sensitive pathway constitutively engaged in the regulation of cerebral hemodynamics(2016)68 cited
- → ADAM17 controls IL-6 signaling by cleavage of the murine IL-6Rα from the cell surface of leukocytes during inflammatory responses(2015)66 cited
- → Short-term TNFα shedding is independent of cytoplasmic phosphorylation or furin cleavage of ADAM17(2013)48 cited
- → Mucus Detachment by Host Metalloprotease Meprin β Requires Shedding of Its Inactive Pro-form, which Is Abrogated by the Pathogenic Protease RgpB(2017)41 cited
- → Polo-like Kinase 2, a Novel ADAM17 Signaling Component, Regulates Tumor Necrosis Factor α Ectodomain Shedding(2013)40 cited
- → Circulating Soluble IL-6R but Not ADAM17 Activation Drives Mononuclear Cell Migration in Tissue Inflammation(2016)20 cited
- → High-risk PCI under support of a pulsatile left ventricular assist device – First German experience with the iVAC2L system(2019)14 cited
- → IMAGINE—IMpact Assessment of Guidelines Implementation and Education: The Next Frontier for Harmonising Urological Practice Across Europe by Improving Adherence to Guidelines(2020)13 cited
- → First high-risk Percutaneous Coronary Intervention Under Use of the iVAC2l System in Germany(2017)10 cited